Monday |
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - $166.72 /
-11.14 (-6.26%) - 01/25/23
- Tesla extends afterhours gains, up over 5% at $152.45
- 01/25/23
- Tesla CEO says Dojo AI to be competitive with Nvidia at end of 2023
- 01/25/23
- Tesla CEO says we have other products in development
- 01/25/23
- Tesla's Musk says probably will have 'difficult recession this year'
- 12/14/22
- SoFi Technologies spikes over 8% after CEO Noto buys $5M in shares
- 12/13/22
- SoFi Technologies CEO buys $5M in common stock
- 11/21/22
- SoFi says cryptocurrency 'non-material component' of business
- 11/21/22
- Sen. Brown, colleagues ask bank regulators to review SoFi's crypto activities
- 01/30/23
- Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization
- 01/27/23
- Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent
- 01/06/23
- 2seventy Bio announces amendment to collaboration with Regeneron
- 01/05/23
- CytomX Therapeutics updates business, announces 2023 relationship with Moderna
- 01/30/23
- Philips sees FY23 comparable sales up low-single-digits
- 01/30/23
- Philips to reduce workforce by additional 3,000 roles in 2023, 6,000 by 2025
- 01/18/23
- Masimo, Philips expands partnership to improve telehealth for patients
- 12/21/22
- Philips gives update on test, research program of PE-PUR sound abatement foam
- 01/12/23
- Okta says there will be some disruption from sales leadership changes
- 01/12/23
- authID integrates Verified CloudConnect with Okta Workforce Identity Cloud
- 12/21/22
- Okta says code repositories copied in early December GitHub hack
- 11/15/22
- Okta debuts 'Okta for US Military' purpose-built identity environment for DoD
- 01/09/23
- Macy's falls -9.0%
- 01/06/23
- Macy's falls 4% to $21.23 after guiding Q4 sales to low-end to midpoint of range
- 11/17/22
- Macy's rises 12.2%
- 11/17/22
- Macy's rises 9.5%
- 01/26/23
- Southwest says it continues to experience year-over-year inflationary pressures
- 01/26/23
- Southwest plans to add 7,000 workers in 2023
- 01/26/23
- Southwest sees FY23 economic fuel costs per gallon $2.90-$3.00
- 01/23/23
- Southwest dispatch staff reaches tentative agreement on contract
- 01/27/23
- Lucid Group trading resumes
- 01/27/23
- Lucid Group trading halted, volatility trading pause
- 01/27/23
- Lucid Group jumps 8% to $9.75 after Betaville mention
- 01/27/23
- Lucid Motors opens first retail studio, service center in Montreal, Quebec
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 11/14/22
- Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron
- 11/08/22
- Ancora supports management transition at Kohl's
- 11/08/22
- Levi Strauss appoints Michelle Gass as President, to succeed Bergh as CEO
- $139.13 /
-1.135 (-0.81%) - 01/20/23
- JPMorgan Asset Management receives approval for 100% ownership of China JV
- 01/13/23
- JPMorgan says continues to expect 17% ROTCE in 2023
- 01/13/23
- JPMorgan says targeting potential $12B in share buybacks in 2023
- 01/13/23
- JPMorgan says investment banking pipeline 'relatively robust'
- 01/30/23
- Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits
- 01/30/23
- J&J drops 3% after court rejects bankruptcy plan for talc lawsuits
- 01/27/23
- Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI
- 01/24/23
- Johnson & Johnson says assuming a lot of inflationary carryover in 2023
- 10/04/22
- Golden Ocean board authorizes $100M share buy-back program
- 01/30/23
- GM Defense, American Rheinmetall win contract for U.S. Army's CTT Program
- 01/20/23
- GM investing $918M in four U.S. facilities for V-8 engines, EV components
- 01/10/23
- RMI launches virtual power plant partnership with GM, Google, Ford
- 01/23/23
- GE HealthCare, Windsor Regional Hospital enter long-term MES agreement
- 01/09/23
- GE HealthCare announces acquisition of CT firm Imactis, terms undisclosed
- 01/09/23
- GE HealthCare to acquire IMACTIS, terms not disclosed
- 01/05/23
- GE HealthCare names Taha Kass-Hout CTO
- 01/06/23
- Flora Growth receives 180 day extension to regain compliance with Nasdaq
- 01/05/23
- Flora Growth provides update on commercial cannabis operations in Colombia
- 11/14/22
- Flora Growth partners with 357 Company to launch 357 Canna Logistics
- 10/24/22
- Flora Growth to acquire medical cannabis Franchise Global Health
- 01/30/23
- Ford to 'significantly increase' Mustang Mach-E production, cut prices
- 01/26/23
- Ford expands complimentary pick-up & delivery mobile service nationwide
- 01/23/23
- Ford sees Q4 pre-tax remeasurement gain of roughly $50M from pension, OPEB plans
- 01/18/23
- EU passenger car registrations up 12.8% in December
- 08/24/22
- Dynex Capital CFO buys $158.4K in common stock
- 01/18/23
- Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs
- 01/17/23
- Ginkgo Bioworks, Xwell expand support for CDC's Genomic Surveillance program
- 01/17/23
- Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC
- 01/09/23
- Ginkgo Bioworks, Prokarium announce RNA collaboration
- 01/30/23
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- 11/14/22
- Third Point buys TJX, exits Cenovus Energy in Q3
- 10/28/22
- Colgate-Palmolive CEO says negative impact from currency accelerated in Q3
- 10/28/22
- Colgate-Palmolive reports Q3 gross profit margin 57.2%, down 220 bps
- 10/21/22
- Sierra Bancorp announces new 630,000 share repurchase program
- 01/11/23
- Franklin Resources reports December AUM of $1.39T vs. $1.41T m/m
- 12/13/22
- Franklin Resources raises quarterly dividend by 3.4% to 30c per share
- 12/09/22
- Franklin Resources Canada announces approval of changes for certain ETFs
- 11/09/22
- Franklin Resources reports AUM of $1.3184T as of October 31, 2022
- 12/05/22
- Axalta Coating enters multiyear agreement with Steer Automotive Group
- 11/16/22
- Axalta Coating appoints Villavarayan as CEO, President, member of board
- 08/29/22
- Axalta Coating appoints Bertsch to board of directors
- 08/29/22
- Axalta Coating appoints Jan Bertsch to board of directors
ARLP Alliance Resource Partners - 01/30/23
- Alliance Resource Partners says well positioned to achieve record year in 2023
- 01/30/23
- Alliance Resource Partners increases unit repurchase program to $100M
- 01/27/23
- Alliance Resource Partners increases distribution 40% to 70c per unit
- 12/08/22
- Alliance Resource Partners names Cary P. Marshall as new CFO
- 11/28/22
- Alpha Metallurgical sees FY23 total shipments 16.7M-18.4M tons
- 09/13/22
- Alpha Metallurgical updates 2023 domestic sales commitments and share repurchase
- 08/08/22
- Alpha Metallurgical increases quarterly dividend to 39.2c from 37.5c per share
- 08/08/22
- Alpha Metallurgical provides 2022 operational guidance
- 01/09/23
- Illumina, Nashville Biosciences announce sequencing agreement with Amgen
- 01/03/23
- Researchers' reanalysis questions mortality data in FOURIER trial
- 12/13/22
- Amgen announces presentation of results from E1910 randomized Phase 3 trial
- 12/12/22
- Amgen raises quarterly dividend by 10% to $2.13
- 01/25/23 BofA
- General Electric price target raised to $92 from $85 at BofA
- 01/19/23 Redburn
- GE HealthCare initiated with a Buy at Redburn
- 01/09/23 BofA
- General Electric price target lowered to $85 from $105 at BofA
- 01/04/23 Edward Jones
- GE HealthCare initiated with a Hold at Edward Jones
- 01/25/23 JPMorgan
- Ford price target lowered to $15 from $16 at JPMorgan
- 01/11/23 Goldman Sachs
- Goldman continues to prefer Tesla and GM among automakers
- 12/21/22 Morgan Stanley
- Tesla shedding $600B of value presents buying opportunity, says Morgan Stanley
- 12/05/22 Jefferies
- Fox Factory price target raised to $135 from $120 at Jefferies
- 01/18/23 Citi
- ResMed upgraded to Buy at Citi as Philips CPAP recall drags on
- 01/17/23 Morgan Stanley
- Philips price target lowered to EUR 16 from EUR 17 at Morgan Stanley
- 01/17/23 UBS
- Philips downgraded to Sell from Neutral at UBS
- 01/10/23 Barclays
- Philips price target lowered to EUR 18.50 from EUR 19 at Barclays
- 01/30/23 Wedbush
- SoFi Technologies price target raised to $8 from $6 at Wedbush
- 01/17/23 JPMorgan
- SoFi Technologies initiated with a Neutral at JPMorgan
- 12/15/22 Piper Sandler
- SoFi Technologies price target lowered to $7.50 from $8.50 at Piper Sandler
- 11/28/22 BofA
- Student loan forbearance extension a near-term headwind for SoFi, says BofA
ARLP Alliance Resource Partners - 03/30/22 Noble Capital
- Alliance Resource Partners initiated with an Outperform at Noble Capital
- $166.72 /
-11.14 (-6.26%) - 01/30/23 Bernstein
- Bernstein sees orders as 'most critical' to Tesla stock
- 01/30/23 Berenberg
- Tesla upgraded to Buy from Hold at Berenberg
- 01/26/23 Morgan Stanley
- Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley
- 01/26/23 Wedbush
- Tesla price target raised to $200 from $175 at Wedbush
- 01/30/23 Cowen
- Regeneron upgraded at Cowen with Eylea 'secure' and pipeline 'delivering'
- 01/30/23 Cowen
- Regeneron upgraded to Outperform from Market Perform at Cowen
- 01/20/23 JPMorgan
- Regeneron upgraded to Overweight from Neutral at JPMorgan
- 01/09/23 Piper Sandler
- Piper 'at a loss' to explain Regeneron Q4 miss for Eylea
- 01/30/23 Stifel
- Okta upgraded to Buy from Hold at Stifel
- 01/24/23 JPMorgan
- Okta initiated with an Overweight at JPMorgan
- 01/23/23 Deutsche Bank
- Okta price target raised to $90 from $80 at Deutsche Bank
- 01/18/23 Scotiabank
- Okta initiated with an Outperform at Scotiabank
- 01/30/23 Craig-Hallum
- Craig-Hallum uncovers 'great buying opportunity' after Friday's confusion
- 01/30/23 Berenberg
- General Motors downgraded to Hold from Buy at Berenberg
- 01/25/23 JPMorgan
- General Motors price target lowered to $57 from $59 at JPMorgan
- 01/19/23 Deutsche Bank
- Deutsche Bank keeps Hold on General Motors, lowers price target to $33
- 01/30/23 Goldman Sachs
- Kohl's initiated with a Sell at Goldman Sachs
- 01/03/23 JPMorgan
- Kohl's price target lowered to $26 from $33 at JPMorgan
- 11/18/22 Gordon Haskett
- Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
- 11/09/22 Morgan Stanley
- Kohl's CEO departure 'unsurprising,' says Morgan Stanley
- 01/30/23 Goldman Sachs
- Macy's initiated with a Buy at Goldman Sachs
- 01/10/23 Guggenheim
- Guggenheim keeps Neutral rating on Macy's following Q4 update
- 01/10/23 Morgan Stanley
- Macy's assumed with an Equal Weight at Morgan Stanley
- 01/10/23 Deutsche Bank
- Macy's price target lowered to $22 from $23 at Deutsche Bank
- 01/19/23 Piper Sandler
- Amgen price target cut at Piper on lower Otezla estimates
- 01/03/23 Barclays
- Research raises 'valid questions' about Amgen's Repatha, says Barclays
- 12/13/22 BMO Capital
- Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
- 12/13/22 Baird
- Amgen deal yields nice accretion but large debt position, says Baird
- 01/27/23 Deutsche Bank
- Southwest price target lowered to $52 from $56 at Deutsche Bank
- 01/27/23 Cowen
- Southwest price target lowered to $50 from $55 at Cowen
- 01/12/23 Barclays
- Southwest price target lowered to $42 from $48 at Barclays
- 01/11/23 Jefferies
- Delta Air Lines price target raised to $45 from $40 at Jefferies
- 01/25/23 Morgan Stanley
- Lucid Group price target lowered to $5 from $10 at Morgan Stanley
- 01/22/23 Citi
- Lucid Group resumed with a Buy at Citi
- 01/12/23 Cantor Fitzgerald
- Lucid's Q4 production pre-announcement 'encouraging, says Cantor Fitzgerald
- 01/12/23 Evercore ISI
- Evercore ISI says Lucid FY/Q4 production serves as glimmer of execution progress
- $139.13 /
-1.135 (-0.81%) - 01/24/23 BofA
- Banks' potential new online wallet unlikely to threaten PayPal, says BofA
- 01/17/23 Citi
- JPMorgan price target raised to $165 from $150 at Citi
- 01/17/23 Piper Sandler
- JPMorgan price target raised to $157 from $150 at Piper Sandler
- 01/06/23 Deutsche Bank
- JPMorgan downgraded to Hold with $145 target at Deutsche Bank
- 01/31/23 Barclays
- Colgate-Palmolive price target lowered to $77 from $80 at Barclays
- 01/30/23 Deutsche Bank
- Colgate-Palmolive price target lowered to $84 from $87 at Deutsche Bank
- 01/30/23 Morgan Stanley
- Colgate-Palmolive upgraded to Overweight from Equal Weight at Morgan Stanley
- 01/13/23 JPMorgan
- Colgate-Palmolive price target raised to $86 from $81 at JPMorgan
- 01/30/23 Fearnley
- Golden Ocean upgraded to Buy from Hold at Fearnley
- 09/26/22 Jefferies
- Golden Ocean downgraded to Hold from Buy at Jefferies
- 07/20/22 Jefferies
- Golden Ocean initiated with a Buy at Jefferies
- 05/20/22 Kepler Cheuvreux
- Golden Ocean downgraded to Hold from Buy at Kepler Cheuvreux
- 01/30/23 Barclays
- Axalta Coating price target raised to $33 from $30 at Barclays
- 01/30/23 Wells Fargo
- Axalta Coating price target raised to $29 from $23 at Wells Fargo
- 01/30/23 Deutsche Bank
- Axalta Coating upgraded to Buy from Hold at Deutsche Bank
- 01/30/23 Citi
- Axalta Coating upgraded to Buy from Neutral at Citi
- 01/27/23 BTIG
- BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
- 01/27/23 Piper Sandler
- Piper keeps $78 target on Legend Biotech after Carvykti trial hits
- 01/25/23 JMP Securities
- J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
- 01/24/23 H.C. Wainwright
- Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 11/28/22 Berenberg
- Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy
- 11/28/22 Berenberg
- Ginkgo Bioworks initiated with a Buy at Berenberg
- 10/04/22 Morgan Stanley
- Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley
- 08/16/22 BTIG
- Ginkgo Bioworks price target raised to $6 from $5 at BTIG
- 12/14/22 Wells Fargo
- Wells Fargo starts Franklin Resources at Underweight on 'tough market'
- 12/14/22 Wells Fargo
- Franklin Resources initiated with an Underweight at Wells Fargo
- 11/15/22 Deutsche Bank
- Franklin Resources price target raised to $26 from $20 at Deutsche Bank
- 10/18/22 Credit Suisse
- Franklin Resources initiated with a Neutral at Credit Suisse
- 01/09/23 Credit Suisse
- Dynex Capital upgraded to Outperform from Neutral at Credit Suisse
- 01/03/23 BTIG
- Dynex Capital named Top Pick for first half of 2023 at BTIG
- 12/19/22 JonesResearch
- Dynex Capital price target raised to $14 from $13.50 at JonesTrading
- 10/24/22 BTIG
- Dynex Capital price target lowered to $13 from $17 at BTIG
- 11/13/22 Keefe Bruyette
- Sierra Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
- 07/07/22 Raymond James
- Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James
- 07/07/22 Raymond James
- Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James
- 01/17/23 B. Riley
- Alpha Metallurgical price target raised to $202 from $193 at B. Riley
- 01/17/23 B. Riley
- B. Riley downgrades trio of coal-linked stocks after updating price deck
- 11/08/22 B. Riley
- Alpha Metallurgical price target raised to $195 from $189 at B. Riley
- 11/08/22 Cowen
- Alpha Metallurgical price target lowered to $215 from $225 at Cowen
- 12/19/22 Alliance Global Partners
- Flora Growth price target lowered to $1.25 from $2 at Alliance Global Partners
- 10/24/22 Alliance Global Partners
- Flora Growth price target lowered to $2 from $2.50 at Alliance Global Partners
- 09/23/22 Alliance Global Partners
- Flora Growth initiated with a Buy at Alliance Global Partners
- 08/01/22 Cantor Fitzgerald
- Cantor starts Flora Growth with Neutral amid diversification process
- $166.72 /
-11.14 (-6.26%) - 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- 01/30/23
- SoFi Technologies sees FY23 revenue $1.93B-$2B, consensus $2B
- 01/30/23
- SoFi Technologies sees Q1 revenue $430M-$440M, consensus $445.82M
- 01/30/23
- SoFi Technologies reports Q4 EPS (5c), consensus (9c)
- 11/01/22
- SoFi Technologies reports Q3 EPS (9c), consensus (10c)
- 01/09/23
- Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea
- 11/03/22
- Regeneron reports Q3 EPS $11.14, consensus $9.48
- 11/02/22
- Notable companies reporting before tomorrow's open
- 01/30/23
- Philips reports Q4 adjusted EPS EUR 0.41 vs. EUR 0.57 last year
- 10/24/22
- Philips reports Q3 adjusted EPS EUR 0.25 vs. EUR 0.40 last year
- 10/12/22
- Philips sees Q3 group revenue EUR 4.3B
- 11/30/22
- Okta raises FY23 EPS view to (27c)-(26c) from (73c)-(70c), consensus (72c)
- 11/30/22
- Okta sees Q4 adjusted EPS 9c-10c, consensus (11c)
- 11/30/22
- Okta reports Q3 adjusted EPS 0c, consensus (24c)
- 11/30/22
- Notable companies reporting after market close
- 01/06/23
- Macy's backs Q4 adjusted EPS view $1.47-$1.67, consensus $1.60
- 11/17/22
- Macy's sees Q4 adjusted EPS $1.47-$1.67, consensus $1.83
- 11/17/22
- Macy's sees Q4 net sales $8.16B-$8.4B, consensus $8.36B
- 11/17/22
- Macy's raises FY22 adjusted EPS view to $4.07-$4.27 from $4.00-$4.20
- 01/26/23
- Southwest sees Q1 revenue up 20%-24%, consensus $5.88B
- 01/26/23
- Southwest reports Q4 adjusted EPS (38c), consensus (9c)
- 01/25/23
- Notable companies reporting before tomorrow's open
- 11/08/22
- Lucid Group reports Q3 EPS (40c), consensus (31c)
- 11/08/22
- Notable companies reporting after market close
- 08/03/22
- Lucid Group reports Q2 EPS (33c), consensus (36c)
- 08/03/22
- Notable companies reporting after market close
- 11/17/22
- Kohl's withdraws FY22 guidance
- 11/17/22
- Kohl's reports Q3 adjusted EPS 82c, consensus 78c
- 11/16/22
- Notable companies reporting before tomorrow's open
- $139.13 /
-1.135 (-0.81%) - 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 01/30/23
- Johnson & Johnson to challenge federal appeals court ruling
- 01/24/23
- Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33
- 08/25/22
- Golden Ocean reports Q2 EPS 82c vs. 63c last year
- 01/30/23
- Notable companies reporting before tomorrow's open
- 11/17/22
- General Motors narrows FY22 EBIT-adjusted view to $13.5B-$14.5B from $13B-$15B
- 10/25/22
- General Motors backs FY22 adjusted EPS view $6.50-$7.50, consensus $6.79
- 10/25/22
- General Motors reports Q3 adjusted EPS $2.25, consensus $1.88
- 01/30/23
- GE HealthCare sees FY23 adjusted EPS $3.60-$3.75
- 01/30/23
- GE HealthCare reports Q4 adjusted EPS $1.31 vs. $1.36 a year ago
- 01/10/23
- GE HealthCare sees FY23 organic revenue growth 5%-7%
- 01/10/23
- GE HealthCare sees FY22 revenue about $18.3B
- 01/30/23
- Flora Growth Sees FY23 revenue $90M-$105M, consensus $95.62M
- 11/28/22
- Flora Growth backs FY22 revenue view $35M-$45M
- 11/28/22
- Flora Growth reports Q3 EPS (10c) vs. (8c) last year
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 10/26/22
- Notable companies reporting after market close
- 01/30/23
- Dynex Capital reports non-GAAP Q4 EPS 3c , consensus 20c
- 01/30/23
- Dynex Capital reports Q4 EPS 85c, consensus 20c
- 10/24/22
- Dynex Capital reports Q3 EPS 24c, consensus 32c
- 01/11/23
- Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M
- 11/14/22
- Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M
- 11/14/22
- Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c)
- 08/15/22
- Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M
- 01/27/23
- Colgate-Palmolive sees 2023 net sales growth 2%-5%, consensus $18.61B
- 01/27/23
- Colgate-Palmolive reports Q4 base EPS 77c, consensus 76c
- 01/26/23
- Notable companies reporting before tomorrow's open
- 01/30/23
- Sierra Bancorp reports Q4 EPS 47c, consensus 71c
- 10/24/22
- Sierra Bancorp reports Q3 EPS 66c, consensus 67c
- 01/30/23
- Franklin Resources reports Q1 EPS 51c, consensus 54c
- 11/01/22
- Franklin Resources reports preliminary Q4 adjusted EPS 78c, consensus 67c
- 01/25/23
- Axalta Coating sees Q1 adjusted EPS 26c-33c, consensus 33c
- 01/25/23
- Axalta Coating reports Q4 adjusted EPS 38c, consensus 35c
- 10/25/22
- Axalta Coating sees Q4 adjusted EPS 31c-39c, consensus 42c
- 10/25/22
- Axalta Coating reports Q3 adjusted EPS 39c, consensus 39c
ARLP Alliance Resource Partners - 01/30/23
- Alliance Resource Partners reports Q4 EPS $1.63, consensus $1.42
- 10/31/22
- Alliance Resource Partners reports Q3 EPS $1.25, consensus $1.50
- 08/01/22
- Alliance Resource Partners reports Q1 EPS $1.23, consensus 95c
- 01/30/23
- Alpha Metallurgical sees Q4 EPS $13.37, consensus $18.14
- 11/07/22
- Alpha Metallurgical reports Q3 EPS $14.21, consensus $16.81
- 08/08/22
- Alpha Metallurgical reports Q2 EPS $30.03, consensus $30.8
- 11/03/22
- Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00
- 11/03/22
- Amgen reports Q3 adjusted EPS $4.70, consensus $4.44
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
|
Earnings
|
Johnson & Johnson… Johnson & Johnson told media outlets that the company will challenge today's federal appeals court ruling rejecting its plan to push about 38,000 talc lawsuits into bankruptcy court. J&J put the talc subsidiary into bankruptcy to equitably resolve the litigation for all parties, including current and future injury claimants, the company said. ShowHide Related Items >><< - 01/30/23
- Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits
- 01/30/23
- J&J drops 3% after court rejects bankruptcy plan for talc lawsuits
- 01/27/23
- Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI
- 01/24/23
- Johnson & Johnson says assuming a lot of inflationary carryover in 2023
- 01/27/23 BTIG
- BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
- 01/27/23 Piper Sandler
- Piper keeps $78 target on Legend Biotech after Carvykti trial hits
- 01/25/23 JMP Securities
- J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
- 01/24/23 H.C. Wainwright
- Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 01/24/23
- Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33
- 01/24/23
- Johnson & Johnson reports Q4 adjusted EPS $2.35, consensus $2.23
- 01/30/23
- Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 01/09/23
- J&J may look for deals that boost eye care, surgical robots units, Reuters says
- 12/04/22
- J&J says won't make offer for Horizon Therapeutics, Bloomberg reports
- 01/30/23
- What You Missed On Wall Street This Morning
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street This Morning
- 01/24/23
- Fly Intel: Pre-market Movers
- 01/30/23
- Johnson & Johnson put volume heavy and directionally bearish
- 01/24/23
- Unusually active option classes on open January 24th
- 01/20/23
- Johnson & Johnson put buyer realizes 33% same-day gains
- 01/11/23
- Unusually active option classes on open January 11th
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 01/25/23
- Tesla extends afterhours gains, up over 5% at $152.45
- 01/25/23
- Tesla CEO says Dojo AI to be competitive with Nvidia at end of 2023
- 01/25/23
- Tesla CEO says we have other products in development
- 01/25/23
- Tesla's Musk says probably will have 'difficult recession this year'
- 12/14/22
- SoFi Technologies spikes over 8% after CEO Noto buys $5M in shares
- 12/13/22
- SoFi Technologies CEO buys $5M in common stock
- 11/21/22
- SoFi says cryptocurrency 'non-material component' of business
- 11/21/22
- Sen. Brown, colleagues ask bank regulators to review SoFi's crypto activities
- 01/24/23
- Rio Tinto trading resumes
- 01/24/23
- Rio Tinto trading halted, volatility trading pause
- 01/17/23
- Rio Tinto guides 2023 Pilbara iron ore shipments 320-335 Mt vs. 322 in 2022
- 01/17/23
- Rio Tinto reports Q4 Pilbara iron ore production 89.5 Mt, up 6% y/y
- $737.85 /
-7.155 (-0.96%) - 01/30/23
- Regeneron, Sanofi announce EC expansion of Dupixent marketing authorization
- 01/27/23
- Regeneron, Sanofi announce CHMP opinion recommending EU approval for Dupixent
- 01/06/23
- 2seventy Bio announces amendment to collaboration with Regeneron
- 01/05/23
- CytomX Therapeutics updates business, announces 2023 relationship with Moderna
- 01/30/23
- Philips sees FY23 comparable sales up low-single-digits
- 01/30/23
- Philips to reduce workforce by additional 3,000 roles in 2023, 6,000 by 2025
- 01/18/23
- Masimo, Philips expands partnership to improve telehealth for patients
- 12/21/22
- Philips gives update on test, research program of PE-PUR sound abatement foam
- 01/12/23
- Okta says there will be some disruption from sales leadership changes
- 01/12/23
- authID integrates Verified CloudConnect with Okta Workforce Identity Cloud
- 12/21/22
- Okta says code repositories copied in early December GitHub hack
- 11/15/22
- Okta debuts 'Okta for US Military' purpose-built identity environment for DoD
- 01/09/23
- Macy's falls -9.0%
- 01/06/23
- Macy's falls 4% to $21.23 after guiding Q4 sales to low-end to midpoint of range
- 11/17/22
- Macy's rises 12.2%
- 11/17/22
- Macy's rises 9.5%
- 01/26/23
- Southwest says it continues to experience year-over-year inflationary pressures
- 01/26/23
- Southwest plans to add 7,000 workers in 2023
- 01/26/23
- Southwest sees FY23 economic fuel costs per gallon $2.90-$3.00
- 01/23/23
- Southwest dispatch staff reaches tentative agreement on contract
- 11/14/22
- Starboard takes stake in Wix.com, exits Elanco Animal Health
- 11/14/22
- Appaloosa exits positions in Kohl's, Occidental Petroleum, Micron
- 11/08/22
- Ancora supports management transition at Kohl's
- 11/08/22
- Levi Strauss appoints Michelle Gass as President, to succeed Bergh as CEO
- 01/30/23
- Johnson & Johnson falls after court rejects bankruptcy plan for talc lawsuits
- 01/30/23
- J&J drops 3% after court rejects bankruptcy plan for talc lawsuits
- 01/27/23
- Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI
- 01/24/23
- Johnson & Johnson says assuming a lot of inflationary carryover in 2023
- 10/04/22
- Golden Ocean board authorizes $100M share buy-back program
- 01/30/23
- GM Defense, American Rheinmetall win contract for U.S. Army's CTT Program
- 01/20/23
- GM investing $918M in four U.S. facilities for V-8 engines, EV components
- 01/10/23
- RMI launches virtual power plant partnership with GM, Google, Ford
- 01/23/23
- GE HealthCare, Windsor Regional Hospital enter long-term MES agreement
- 01/09/23
- GE HealthCare announces acquisition of CT firm Imactis, terms undisclosed
- 01/09/23
- GE HealthCare to acquire IMACTIS, terms not disclosed
- 01/05/23
- GE HealthCare names Taha Kass-Hout CTO
- 01/06/23
- Flora Growth receives 180 day extension to regain compliance with Nasdaq
- 01/05/23
- Flora Growth provides update on commercial cannabis operations in Colombia
- 11/14/22
- Flora Growth partners with 357 Company to launch 357 Canna Logistics
- 10/24/22
- Flora Growth to acquire medical cannabis Franchise Global Health
- 01/30/23
- Ford to 'significantly increase' Mustang Mach-E production, cut prices
- 01/26/23
- Ford expands complimentary pick-up & delivery mobile service nationwide
- 01/23/23
- Ford sees Q4 pre-tax remeasurement gain of roughly $50M from pension, OPEB plans
- 01/18/23
- EU passenger car registrations up 12.8% in December
- 08/24/22
- Dynex Capital CFO buys $158.4K in common stock
- 01/18/23
- Ginkgo Bioworks and NAMUH announce collaboration to develop HMOs
- 01/17/23
- Ginkgo Bioworks, Xwell expand support for CDC's Genomic Surveillance program
- 01/17/23
- Ginkgo Bioworks and Xwell partner in influenza variant detection for CDC
- 01/09/23
- Ginkgo Bioworks, Prokarium announce RNA collaboration
- 01/30/23
- Colgate-Palmolive names Steve Cahillane to Board of Directors
- 11/14/22
- Third Point buys TJX, exits Cenovus Energy in Q3
- 10/28/22
- Colgate-Palmolive CEO says negative impact from currency accelerated in Q3
- 10/28/22
- Colgate-Palmolive reports Q3 gross profit margin 57.2%, down 220 bps
- 01/11/23
- COPT forms two data center JVs with Blackstone Real Estate
- 01/03/23
- UC Investments to invest $4B in Blackstone Real Estate Income Trust
- 01/03/23
- Targa to acquire Blackstone's 25% interest in Grand Prix for $1.05B
- 12/12/22
- Thomson Reuters, Blackstone to sell shares of LSEG to Microsoft
- 10/21/22
- Sierra Bancorp announces new 630,000 share repurchase program
- 01/11/23
- Franklin Resources reports December AUM of $1.39T vs. $1.41T m/m
- 12/13/22
- Franklin Resources raises quarterly dividend by 3.4% to 30c per share
- 12/09/22
- Franklin Resources Canada announces approval of changes for certain ETFs
- 11/09/22
- Franklin Resources reports AUM of $1.3184T as of October 31, 2022
- 12/05/22
- Axalta Coating enters multiyear agreement with Steer Automotive Group
- 11/16/22
- Axalta Coating appoints Villavarayan as CEO, President, member of board
- 08/29/22
- Axalta Coating appoints Bertsch to board of directors
- 08/29/22
- Axalta Coating appoints Jan Bertsch to board of directors
ARLP Alliance Resource Partners - 01/30/23
- Alliance Resource Partners says well positioned to achieve record year in 2023
- 01/30/23
- Alliance Resource Partners increases unit repurchase program to $100M
- 01/27/23
- Alliance Resource Partners increases distribution 40% to 70c per unit
- 12/08/22
- Alliance Resource Partners names Cary P. Marshall as new CFO
- 11/28/22
- Alpha Metallurgical sees FY23 total shipments 16.7M-18.4M tons
- 09/13/22
- Alpha Metallurgical updates 2023 domestic sales commitments and share repurchase
- 08/08/22
- Alpha Metallurgical increases quarterly dividend to 39.2c from 37.5c per share
- 08/08/22
- Alpha Metallurgical provides 2022 operational guidance
- 01/09/23
- Illumina, Nashville Biosciences announce sequencing agreement with Amgen
- 01/03/23
- Researchers' reanalysis questions mortality data in FOURIER trial
- 12/13/22
- Amgen announces presentation of results from E1910 randomized Phase 3 trial
- 12/12/22
- Amgen raises quarterly dividend by 10% to $2.13
- 01/25/23 BofA
- General Electric price target raised to $92 from $85 at BofA
- 01/19/23 Redburn
- GE HealthCare initiated with a Buy at Redburn
- 01/09/23 BofA
- General Electric price target lowered to $85 from $105 at BofA
- 01/04/23 Edward Jones
- GE HealthCare initiated with a Hold at Edward Jones
- 01/25/23 JPMorgan
- Ford price target lowered to $15 from $16 at JPMorgan
- 01/11/23 Goldman Sachs
- Goldman continues to prefer Tesla and GM among automakers
- 12/21/22 Morgan Stanley
- Tesla shedding $600B of value presents buying opportunity, says Morgan Stanley
- 12/05/22 Jefferies
- Fox Factory price target raised to $135 from $120 at Jefferies
- 01/18/23 Citi
- ResMed upgraded to Buy at Citi as Philips CPAP recall drags on
- 01/17/23 Morgan Stanley
- Philips price target lowered to EUR 16 from EUR 17 at Morgan Stanley
- 01/17/23 UBS
- Philips downgraded to Sell from Neutral at UBS
- 01/10/23 Barclays
- Philips price target lowered to EUR 18.50 from EUR 19 at Barclays
- 01/17/23 JPMorgan
- SoFi Technologies initiated with a Neutral at JPMorgan
- 12/15/22 Piper Sandler
- SoFi Technologies price target lowered to $7.50 from $8.50 at Piper Sandler
- 11/28/22 BofA
- Student loan forbearance extension a near-term headwind for SoFi, says BofA
- 11/23/22 Mizuho
- SoFi Technologies price target lowered to $6 from $7 at Mizuho
ARLP Alliance Resource Partners - 03/30/22 Noble Capital
- Alliance Resource Partners initiated with an Outperform at Noble Capital
- 01/30/23 Bernstein
- Bernstein sees orders as 'most critical' to Tesla stock
- 01/30/23 Berenberg
- Tesla upgraded to Buy from Hold at Berenberg
- 01/26/23 Morgan Stanley
- Tesla FY23 earnings could bottom near $3 per share, says Morgan Stanley
- 01/26/23 Wedbush
- Tesla price target raised to $200 from $175 at Wedbush
- 01/30/23 Craig-Hallum
- Craig-Hallum uncovers 'great buying opportunity' after Friday's confusion
- 01/30/23 Berenberg
- General Motors downgraded to Hold from Buy at Berenberg
- 01/25/23 JPMorgan
- General Motors price target lowered to $57 from $59 at JPMorgan
- 01/19/23 Deutsche Bank
- Deutsche Bank keeps Hold on General Motors, lowers price target to $33
- $737.85 /
-7.155 (-0.96%) - 01/30/23 Cowen
- Regeneron upgraded at Cowen with Eylea 'secure' and pipeline 'delivering'
- 01/30/23 Cowen
- Regeneron upgraded to Outperform from Market Perform at Cowen
- 01/20/23 JPMorgan
- Regeneron upgraded to Overweight from Neutral at JPMorgan
- 01/09/23 Piper Sandler
- Piper 'at a loss' to explain Regeneron Q4 miss for Eylea
- 01/30/23 Stifel
- Okta upgraded to Buy from Hold at Stifel
- 01/24/23 JPMorgan
- Okta initiated with an Overweight at JPMorgan
- 01/23/23 Deutsche Bank
- Okta price target raised to $90 from $80 at Deutsche Bank
- 01/18/23 Scotiabank
- Okta initiated with an Outperform at Scotiabank
- 01/30/23 Goldman Sachs
- Macy's initiated with a Buy at Goldman Sachs
- 01/10/23 Guggenheim
- Guggenheim keeps Neutral rating on Macy's following Q4 update
- 01/10/23 Morgan Stanley
- Macy's assumed with an Equal Weight at Morgan Stanley
- 01/10/23 Deutsche Bank
- Macy's price target lowered to $22 from $23 at Deutsche Bank
- 01/30/23 Goldman Sachs
- Kohl's initiated with a Sell at Goldman Sachs
- 01/03/23 JPMorgan
- Kohl's price target lowered to $26 from $33 at JPMorgan
- 11/18/22 Gordon Haskett
- Ross Stores upgraded to Buy at Gordon Haskett as off-price starts to turn corner
- 11/09/22 Morgan Stanley
- Kohl's CEO departure 'unsurprising,' says Morgan Stanley
- 01/19/23 Piper Sandler
- Amgen price target cut at Piper on lower Otezla estimates
- 01/03/23 Barclays
- Research raises 'valid questions' about Amgen's Repatha, says Barclays
- 12/13/22 BMO Capital
- Horizon Therapeutics downgraded to Market Perform from Outperform at BMO Capital
- 12/13/22 Baird
- Amgen deal yields nice accretion but large debt position, says Baird
- 01/27/23 Deutsche Bank
- Southwest price target lowered to $52 from $56 at Deutsche Bank
- 01/27/23 Cowen
- Southwest price target lowered to $50 from $55 at Cowen
- 01/12/23 Barclays
- Southwest price target lowered to $42 from $48 at Barclays
- 01/11/23 Jefferies
- Delta Air Lines price target raised to $45 from $40 at Jefferies
- 01/27/23 BMO Capital
- Blackstone price target raised to $92 from $85 at BMO Capital
- 01/27/23 Barclays
- Blackstone price target raised to $100 from $86 at Barclays
- 01/24/23 JPMorgan
- TPG downgraded to Neutral from Overweight at JPMorgan
- 01/24/23 JPMorgan
- Blackstone upgraded to Overweight from Neutral at JPMorgan
- 01/23/23 Morgan Stanley
- Rio Tinto price target raised to 5,790 GBp from 5,750 GBp at Morgan Stanley
- 01/18/23 JPMorgan
- Rio Tinto price target raised to 5,380 GBp from 5,310 GBp at JPMorgan
- 01/17/23 CLSA
- Rio Tinto downgraded to Underperform from Outperform at CLSA
- 01/12/23 Barclays
- Rio Tinto upgraded to Equal Weight from Underweight at Barclays
- 01/30/23 Deutsche Bank
- Colgate-Palmolive price target lowered to $84 from $87 at Deutsche Bank
- 01/30/23 Morgan Stanley
- Colgate-Palmolive upgraded to Overweight from Equal Weight at Morgan Stanley
- 01/13/23 JPMorgan
- Colgate-Palmolive price target raised to $86 from $81 at JPMorgan
- 12/06/22 Deutsche Bank
- Colgate-Palmolive price target raised to $87 from $85 at Deutsche Bank
- 01/30/23 Fearnley
- Golden Ocean upgraded to Buy from Hold at Fearnley
- 09/26/22 Jefferies
- Golden Ocean downgraded to Hold from Buy at Jefferies
- 07/20/22 Jefferies
- Golden Ocean initiated with a Buy at Jefferies
- 05/20/22 Kepler Cheuvreux
- Golden Ocean downgraded to Hold from Buy at Kepler Cheuvreux
- 01/30/23 Barclays
- Axalta Coating price target raised to $33 from $30 at Barclays
- 01/30/23 Wells Fargo
- Axalta Coating price target raised to $29 from $23 at Wells Fargo
- 01/30/23 Deutsche Bank
- Axalta Coating upgraded to Buy from Hold at Deutsche Bank
- 01/30/23 Citi
- Axalta Coating upgraded to Buy from Neutral at Citi
- 11/28/22 Berenberg
- Berenberg starts 'well-positioned' disruptor Ginkgo Bioworks with a Buy
- 11/28/22 Berenberg
- Ginkgo Bioworks initiated with a Buy at Berenberg
- 10/04/22 Morgan Stanley
- Ginkgo Bioworks initiated with an Equal Weight at Morgan Stanley
- 08/16/22 BTIG
- Ginkgo Bioworks price target raised to $6 from $5 at BTIG
- 12/14/22 Wells Fargo
- Wells Fargo starts Franklin Resources at Underweight on 'tough market'
- 12/14/22 Wells Fargo
- Franklin Resources initiated with an Underweight at Wells Fargo
- 11/15/22 Deutsche Bank
- Franklin Resources price target raised to $26 from $20 at Deutsche Bank
- 10/18/22 Credit Suisse
- Franklin Resources initiated with a Neutral at Credit Suisse
- 01/09/23 Credit Suisse
- Dynex Capital upgraded to Outperform from Neutral at Credit Suisse
- 01/03/23 BTIG
- Dynex Capital named Top Pick for first half of 2023 at BTIG
- 12/19/22 JonesResearch
- Dynex Capital price target raised to $14 from $13.50 at JonesTrading
- 10/24/22 BTIG
- Dynex Capital price target lowered to $13 from $17 at BTIG
- 11/13/22 Keefe Bruyette
- Sierra Bancorp downgraded to Market Perform from Outperform at Keefe Bruyette
- 07/07/22 Raymond James
- Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James
- 07/07/22 Raymond James
- Sierra Bancorp downgraded to Market Perform from Outperform at Raymond James
- 01/17/23 B. Riley
- Alpha Metallurgical price target raised to $202 from $193 at B. Riley
- 01/17/23 B. Riley
- B. Riley downgrades trio of coal-linked stocks after updating price deck
- 11/08/22 B. Riley
- Alpha Metallurgical price target raised to $195 from $189 at B. Riley
- 11/08/22 Cowen
- Alpha Metallurgical price target lowered to $215 from $225 at Cowen
- 12/19/22 Alliance Global Partners
- Flora Growth price target lowered to $1.25 from $2 at Alliance Global Partners
- 10/24/22 Alliance Global Partners
- Flora Growth price target lowered to $2 from $2.50 at Alliance Global Partners
- 09/23/22 Alliance Global Partners
- Flora Growth initiated with a Buy at Alliance Global Partners
- 08/01/22 Cantor Fitzgerald
- Cantor starts Flora Growth with Neutral amid diversification process
- 01/27/23 BTIG
- BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
- 01/27/23 Piper Sandler
- Piper keeps $78 target on Legend Biotech after Carvykti trial hits
- 01/25/23 JMP Securities
- J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
- 01/24/23 H.C. Wainwright
- Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 10/19/22
- Notable companies reporting after market close
- 01/30/23
- SoFi Technologies sees FY23 revenue $1.93B-$2B, consensus $2B
- 01/30/23
- SoFi Technologies sees Q1 revenue $430M-$440M, consensus $445.82M
- 01/30/23
- SoFi Technologies reports Q4 EPS (5c), consensus (9c)
- 11/01/22
- SoFi Technologies reports Q3 EPS (9c), consensus (10c)
- $737.85 /
-7.155 (-0.96%) - 01/09/23
- Regeneron sees about $1.5B in Q4 U.S. net product sales of Eylea
- 11/03/22
- Regeneron reports Q3 EPS $11.14, consensus $9.48
- 11/02/22
- Notable companies reporting before tomorrow's open
- 01/30/23
- Philips reports Q4 adjusted EPS EUR 0.41 vs. EUR 0.57 last year
- 10/24/22
- Philips reports Q3 adjusted EPS EUR 0.25 vs. EUR 0.40 last year
- 10/12/22
- Philips sees Q3 group revenue EUR 4.3B
- 11/30/22
- Okta raises FY23 EPS view to (27c)-(26c) from (73c)-(70c), consensus (72c)
- 11/30/22
- Okta sees Q4 adjusted EPS 9c-10c, consensus (11c)
- 11/30/22
- Okta reports Q3 adjusted EPS 0c, consensus (24c)
- 11/30/22
- Notable companies reporting after market close
- 01/06/23
- Macy's backs Q4 adjusted EPS view $1.47-$1.67, consensus $1.60
- 11/17/22
- Macy's sees Q4 adjusted EPS $1.47-$1.67, consensus $1.83
- 11/17/22
- Macy's sees Q4 net sales $8.16B-$8.4B, consensus $8.36B
- 11/17/22
- Macy's raises FY22 adjusted EPS view to $4.07-$4.27 from $4.00-$4.20
- 01/26/23
- Southwest sees Q1 revenue up 20%-24%, consensus $5.88B
- 01/26/23
- Southwest reports Q4 adjusted EPS (38c), consensus (9c)
- 01/25/23
- Notable companies reporting before tomorrow's open
- 11/17/22
- Kohl's withdraws FY22 guidance
- 11/17/22
- Kohl's reports Q3 adjusted EPS 82c, consensus 78c
- 11/16/22
- Notable companies reporting before tomorrow's open
- 01/24/23
- Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33
- 01/24/23
- Johnson & Johnson reports Q4 adjusted EPS $2.35, consensus $2.23
- 08/25/22
- Golden Ocean reports Q2 EPS 82c vs. 63c last year
- 11/17/22
- General Motors narrows FY22 EBIT-adjusted view to $13.5B-$14.5B from $13B-$15B
- 10/25/22
- General Motors backs FY22 adjusted EPS view $6.50-$7.50, consensus $6.79
- 10/25/22
- General Motors reports Q3 adjusted EPS $2.25, consensus $1.88
- 10/24/22
- Notable companies reporting before tomorrow's open
- 01/30/23
- GE HealthCare sees FY23 adjusted EPS $3.60-$3.75
- 01/30/23
- GE HealthCare reports Q4 adjusted EPS $1.31 vs. $1.36 a year ago
- 01/10/23
- GE HealthCare sees FY23 organic revenue growth 5%-7%
- 01/10/23
- GE HealthCare sees FY22 revenue about $18.3B
- 01/30/23
- Flora Growth Sees FY23 revenue $90M-$105M, consensus $95.62M
- 11/28/22
- Flora Growth backs FY22 revenue view $35M-$45M
- 11/28/22
- Flora Growth reports Q3 EPS (10c) vs. (8c) last year
- 10/26/22
- Ford reports Q3 adjusted EPS 39c, consensus 27c
- 10/26/22
- Notable companies reporting after market close
- 01/30/23
- Dynex Capital reports non-GAAP Q4 EPS 3c , consensus 20c
- 01/30/23
- Dynex Capital reports Q4 EPS 85c, consensus 20c
- 10/24/22
- Dynex Capital reports Q3 EPS 24c, consensus 32c
- 01/11/23
- Ginkgo Bioworks backs FY22 revenue view $460M-$480M, consensus $470.79M
- 11/14/22
- Ginkgo Bioworks sees FY22 revenue $425M-$440M, consensus $435.34M
- 11/14/22
- Ginkgo Bioworks reports Q3 EPS (41c), consensus (30c)
- 08/15/22
- Ginkgo Bioworks raises FY22 revenue view to $425M-$440M from $375M-$390M
- 01/27/23
- Colgate-Palmolive sees 2023 net sales growth 2%-5%, consensus $18.61B
- 01/27/23
- Colgate-Palmolive reports Q4 base EPS 77c, consensus 76c
- 01/26/23
- Notable companies reporting before tomorrow's open
- 01/27/23
- Blackstone reports Q4 distributable EPS $1.07 vs. $1.71 y/y
- 01/25/23
- UC Investments to invest additional $500M in BREIT common shares
- 01/30/23
- Sierra Bancorp reports Q4 EPS 47c, consensus 71c
- 10/24/22
- Sierra Bancorp reports Q3 EPS 66c, consensus 67c
- 01/30/23
- Franklin Resources reports Q1 EPS 51c, consensus 54c
- 11/01/22
- Franklin Resources reports preliminary Q4 adjusted EPS 78c, consensus 67c
- 01/25/23
- Axalta Coating sees Q1 adjusted EPS 26c-33c, consensus 33c
- 01/25/23
- Axalta Coating reports Q4 adjusted EPS 38c, consensus 35c
- 10/25/22
- Axalta Coating sees Q4 adjusted EPS 31c-39c, consensus 42c
- 10/25/22
- Axalta Coating reports Q3 adjusted EPS 39c, consensus 39c
ARLP Alliance Resource Partners - 01/30/23
- Alliance Resource Partners reports Q4 EPS $1.63, consensus $1.42
- 10/31/22
- Alliance Resource Partners reports Q3 EPS $1.25, consensus $1.50
- 08/01/22
- Alliance Resource Partners reports Q1 EPS $1.23, consensus 95c
- 01/30/23
- Alpha Metallurgical sees Q4 EPS $13.37, consensus $18.14
- 11/07/22
- Alpha Metallurgical reports Q3 EPS $14.21, consensus $16.81
- 08/08/22
- Alpha Metallurgical reports Q2 EPS $30.03, consensus $30.8
- 11/03/22
- Amgen narrows FY22 adjusted EPS view to $17.25-$17.85 from $17.00-$18.00
- 11/03/22
- Amgen reports Q3 adjusted EPS $4.70, consensus $4.44
- 11/03/22
- Notable companies reporting after market close
- 08/04/22
- Amgen backs FY22 adjusted EPS view $17.00-$18.00, consensus $17.40
|
Hot Stocks
|
Shares of Johnson &… Shares of Johnson & Johnson have moved lower in late morning trading after the United States Court of Appeals for the Third Circuit court rejected the company's plan to use a legal strategy to push about 38,000 talc lawsuits into bankruptcy court. In a ruling posted to the court's site, the circuit judges wrote: "These cases came to be heard on the record before the United States Bankruptcy Court for the District of New Jersey and were argued on September 19, 2022. On consideration whereof, it is ordered and adjudged by this Court that the order of the Bankruptcy Court entered March 2, 2022 is reversed and the case is remanded with the instruction to dismiss Appellee's Chapter 11 petition. The order of the Bankruptcy Court entered March 4, 2022 is vacated as moot." In Monday morning trading following news of the appeals court ruling, shares of Johnson & Johnson are down $4.46, or 3%, to $163.76. ShowHide Related Items >><< - 01/30/23
- J&J drops 3% after court rejects bankruptcy plan for talc lawsuits
- 01/27/23
- Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI
- 01/24/23
- Johnson & Johnson says assuming a lot of inflationary carryover in 2023
- 01/24/23
- Johnson & Johnson sees 'above market growth' in Pharmaceutical segment in FY23
- 01/27/23 BTIG
- BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
- 01/27/23 Piper Sandler
- Piper keeps $78 target on Legend Biotech after Carvykti trial hits
- 01/25/23 JMP Securities
- J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
- 01/24/23 H.C. Wainwright
- Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 01/24/23
- Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33
- 01/24/23
- Johnson & Johnson reports Q4 adjusted EPS $2.35, consensus $2.23
- 01/30/23
- Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 01/09/23
- J&J may look for deals that boost eye care, surgical robots units, Reuters says
- 12/04/22
- J&J says won't make offer for Horizon Therapeutics, Bloomberg reports
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street This Morning
- 01/24/23
- Fly Intel: Pre-market Movers
- 01/07/23
- Short Report: Bad News Bears continue to claw Silvergate, Futu Holdings
- 01/30/23
- Johnson & Johnson put volume heavy and directionally bearish
- 01/24/23
- Unusually active option classes on open January 24th
- 01/20/23
- Johnson & Johnson put buyer realizes 33% same-day gains
- 01/11/23
- Unusually active option classes on open January 11th
|
Hot Stocks
| ShowHide Related Items >><< - 01/27/23
- Janssen announces unblinding of Phase 3 CARTITUDE-4 study of CARVYKTI
- 01/24/23
- Johnson & Johnson says assuming a lot of inflationary carryover in 2023
- 01/24/23
- Johnson & Johnson sees 'above market growth' in Pharmaceutical segment in FY23
- 01/24/23
- Johnson & Johnson expects FY23 OPEX leverage offset by inflationary pressures
- 01/27/23 BTIG
- BTIG sees Legend commercializing Carvykti in earlier lines after study hits goal
- 01/27/23 Piper Sandler
- Piper keeps $78 target on Legend Biotech after Carvykti trial hits
- 01/25/23 JMP Securities
- J&J conference call comments 'a good sign' for Protagonist, says JMP Securities
- 01/24/23 H.C. Wainwright
- Fate Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
- 01/24/23
- Johnson & Johnson sees FY23 adjusted EPS $10.45- $10.65, consensus $10.33
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operational EPS $10.40-$10.60
- 01/24/23
- Johnson & Johnson sees FY23 adjusted operation EPS $10.50, consensus $10.33
- 01/24/23
- Johnson & Johnson reports Q4 adjusted EPS $2.35, consensus $2.23
- 01/30/23
- Appeals court dismisses Chapter 11 case of J&J unit, WSJ reports
- 01/13/23
- Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports
- 01/09/23
- J&J may look for deals that boost eye care, surgical robots units, Reuters says
- 12/04/22
- J&J says won't make offer for Horizon Therapeutics, Bloomberg reports
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street This Morning
- 01/24/23
- Fly Intel: Pre-market Movers
- 01/07/23
- Short Report: Bad News Bears continue to claw Silvergate, Futu Holdings
- 01/30/23
- Johnson & Johnson put volume heavy and directionally bearish
- 01/24/23
- Unusually active option classes on open January 24th
- 01/20/23
- Johnson & Johnson put buyer realizes 33% same-day gains
- 01/11/23
- Unusually active option classes on open January 11th
|